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Principle Investigator: Martin L. Smith, Ph.D., Indiana University School of Medicine, 
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We are currently researching the DNA repair gene Xeroderma Pigmentosa 
complement group C (XPC) and its regulation. XPC is a key recognition factor in 
Nucleotide Excision Repair (NER) responsible for recognizing DNA damage and 
initiating Global Genomic-Nucleotide Excision Repair. Studies have shown that 
XPC mutations and deletions are associated with increased sensitivity to DNA 
damage and increased cancer risk. While it is known that XPC is modified by 
ubiquitination, the ubiquitin ligase associated with its regulation has not been 
identified. To this end we will investigate the regulation of XPC and its role in 
NER and cell cycle and cancer progression via tissue culture transfections, co-
transfections, Western blot analysis, host cell reactivation (HCR), and flow 
cytometry. 
  
 
Coactivator Associated Arginine Methyltransferase-1 (CARM1) mediation of human 
mammary epithelial cell immortalization 
Principle Investigator: Meei-Huey Jeng, Ph.D., Indiana University School of Medicine, 
2005-2008 
 
This investigation utilized retroviral system of transduction to overexpress 
CARM1 in Human Mammary Epithelial Cells (HMECs). Preliminary data 
showed that breast cells transfected with CARM1 increased telomerase activity as 
well as telomere length. We hypothesized that the overexpression of CARM1 
protein may be sufficient to extend the lifespan of primary HMECs in culture. 
This was investigated via primary cell transduction, Western blot, and Telomeric 
Repeat Amplification Protocol (TRAP). This study is ongoing. 
     
       
Defining the role of the E7 protein in the Life Cycle of Human Papillomavirus 
Principle Investigator: Ann Roman, Ph.D., Indiana University School of Medicine, 
Summer 2004 
 
This study helped to provide an increased understanding of the E7 protein of high 
risk (ie. HPV16) and low risk (ie. HPV6) viruses. A mutation of the wildtype 
HPV6E7 was generated to characterize a potential gain of function required for 
binding to the tumor suppressor retinoblastoma protein, pRB, family members. 
These data will help to determine the interaction of the E7 protein in HPV.  
 
 
 
The Effects of Demineralized Bone Matrix Proteins and Osteogenic Protein-1 on Bone 
Cells Isolated in Culture 
Principle Investigators: Michelle Tucci, Ph.D., Hamed Benghuzzi, Ph.D. and Joseph A. 
Cameron, Ph.D., University of Mississippi Medical Center and Jackson State University, 
2003-2004 
    
     Demineralized bone matrix protein (DBM) has been used to reconstruct bone. 
Studies have shown that DBM induces new bone formation when it is 
subcutaneously or intramuscularly implanted. DBX, a type or demineralized bone 
matrix, is a combination of several different proteins including Osteogenic Protein 
-1 (Op-1). OP-1 was the first bone morphogenic protein approved for clinical use 
in the United States. MG63 osteosarcoma cells were treated with high and low 
concentrations of either DBX or OP-1 and evaluated at different time points for 
changes in cell morphology, cell damage, cell number, and protein concentration. 
Results indicate a more substantial increase in bone cell proliferation in cells 
treated with DBX then in those treated with Op-1. This suggests that DBX 
provides the most effective treatment for bone cell proliferation.   
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